The Indian pharmaceutical industry has been granted approval to produce peptide diabetes drugs under the Production Linked Incentive (PLI) scheme. This move will not only boost the production of essential medications for diabetes patients but also create new job opportunities in the sector. The Pharma department is hopeful that this initiative will help make these life-saving drugs more accessible and affordable for those in need.
Source link
What is Operation Midnight Hammer? 'Deliberate, precise' strike by US on Iran – details
About the AuthorTOI World DeskThe TOI World Desk comprises a team of experienced journalists and writers dedicated to delivering timely and accurate news on global events and international affairs, ensuring readers receive a well-rounded understanding of the world's complexities. Their commitment to depth and nuance fosters informed perspectives on the interconnected stories that shape our global landscape.Read More Need More Context? 🔎
Read more